Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Pattillo RA, Hussa RO, Story MT, Ruckert AC, Shalaby MR, Mattingly RF (1977) Science 196: 1456-8 Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. Levine GN, D'Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, Milani RV, Sagalowsky AI, Smith MR, Zakai N, American Heart Association Council on Clinical Cardiology and Council on Epidemiology and Prevention, the American Cancer Society, and the American Urological Association (2010) Circulation 121: 833-40 Urological cancer: walking the tightrope of survival and quality of life with ADT. Resnick MJ (2013) Nat Rev Clin Oncol 10: 307-8 A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man. Evans RM, Doelle GC, Lindner J, Bradley V, Rabin D (1984) J Clin Invest 73: 262-6 Cytological localization of chorionic gonadotropin alpha and placental lactogen mRNAs during development of the human placenta. Hoshina M, Boothby M, Boime I (1982) J Cell Biol 93: 190-8 The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization. Mukherjee S, Gurevich VV, Jones JC, Casanova JE, Frank SR, Maizels ET, Bader MF, Kahn RA, Palczewski K, Aktories K, Hunzicker-Dunn M (2000) Proc Natl Acad Sci U S A 97: 5901-6 Segregation patterns of polymorphic restriction sites of the gene encoding the alpha subunit of human chorionic gonadotropin in trophoblastic disease. Hoshina M, Boothby MR, Hussa RD, Pattillo RA, Camel HM, Boime I (1984) Proc Natl Acad Sci U S A 81: 2504-7 Expression of the TAL1/SCL transcription factor in physiological and pathological vascular processes. Tang T, Shi Y, Opalenik SR, Brantley-Sieders DM, Chen J, Davidson JM, Brandt SJ (2006) J Pathol 210: 121-9 Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men. Pavlou SN, Wakefield G, Schlechter NL, Lindner J, Souza KH, Kamilaris TC, Konidaris S, Rivier JE, Vale WW, Toglia M (1989) J Clin Endocrinol Metab 68: 446-54 Characterization of human anti-luteinizing hormone-releasing hormone (LRH) antibodies in the serum of a patient with isolated gonadotropin deficiency treated with synthetic LRH. Lindner J, McNeil LW, Marney S, Conway M, Rivier J, Vale W, Rabin D (1981) J Clin Endocrinol Metab 52: 267-70 Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido. Pavlou SN, Brewer K, Farley MG, Lindner J, Bastias MC, Rogers BJ, Swift LL, Rivier JE, Vale WW, Conn PM (1991) J Clin Endocrinol Metab 73: 1360-9 Regulation of pituitary glycoprotein alpha-subunit secretion after administration of a luteinizing hormone-releasing hormone antagonist in normal men. Lindner J, Rivier JE, Vale WW, Pavlou SN (1990) J Clin Endocrinol Metab 70: 1219-24 Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration. Pavlou SN, Dahl KD, Wakefield G, Rivier J, Vale W, Hsueh AJ, Lindner J (1988) J Clin Endocrinol Metab 66: 1005-9 Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men. Pavlou SN, Veldhuis JD, Lindner J, Souza KH, Urban RJ, Rivier JE, Vale WW, Stallard DJ (1990) J Clin Endocrinol Metab 70: 1472-8 Epidermal growth factor stimulates secretion of human chorionic gonadotropin by cultured human choriocarcinoma cells. Benveniste R, Speeg KV, Carpenter G, Cohen S, Lindner J, Rabinowitz D (1978) J Clin Endocrinol Metab 46: 169-72 Ovarian steroids differentially modulate the gene expression of gonadotropin-releasing hormone neuronal subtypes in the ovariectomized cynomolgus monkey. Krajewski SJ, Abel TW, Voytko ML, Rance NE (2003) J Clin Endocrinol Metab 88: 655-62 Stimulatory effects of interleukin-induced activation of the hypothalamo-pituitary-adrenal axis on gonadotropin secretion in ovariectomized monkeys replaced with estradiol. Xiao E, Xia L, Shanen D, Khabele D, Ferin M (1994) Endocrinology 135: 2093-8 Estradiol-17 beta and mu-opioid peptides rapidly hyperpolarize GnRH neurons: a cellular mechanism of negative feedback? Lagrange AH, Rønnekleiv OK, Kelly MJ (1995) Endocrinology 136: 2341-4 P450(17 alpha) and P450SCC gene expression and regulation in the rat placenta. Durkee TJ, McLean MP, Hales DB, Payne AH, Waterman MR, Khan I, Gibori G (1992) Endocrinology 130: 1309-17 Human chorionic gonadotropin alpha-subunit from cultured choriocarcinoma (JEG) cells: comparison of the subunit secreted free with that prepared from secreted human chorionic gonadotropin. Benveniste R, Lindner J, Puett D, Rabin D (1979) Endocrinology 105: 581-7 Imbalanced synthesis of human choriogonadotropin alpha and beta subunits reflects the steady state levels of the corresponding mRNAs. Boothby M, Kukowska J, Boime I (1983) J Biol Chem 258: 9250-3 Expression and purification of functional human 17 alpha-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17 alpha-hydroxylase/17,20-lyase deficiency. Imai T, Globerman H, Gertner JM, Kagawa N, Waterman MR (1993) J Biol Chem 268: 19681-9 Transcriptional regulation of the bovine CYP17 (P-450(17)alpha) gene. Identification of two cAMP regulatory regions lacking the consensus cAMP-responsive element (CRE). Lund J, Ahlgren R, Wu DH, Kagimoto M, Simpson ER, Waterman MR (1990) J Biol Chem 265: 3304-12 Gonadotrope-specific deletion of Dicer results in severely suppressed gonadotropins and fertility defects. Wang H, Graham I, Hastings R, Gunewardena S, Brinkmeier ML, Conn PM, Camper SA, Kumar TR (2015) J Biol Chem 290: 2699-714 The beta subunit of human chorionic gonadotropin is encoded by multiple genes. Policastro P, Ovitt CE, Hoshina M, Fukuoka H, Boothby MR, Boime I (1983) J Biol Chem 258: 11492-9 A single gonadotropin alpha-subunit gene in normal tissue and tumor-derived cell lines. Boothby M, Ruddon RW, Anderson C, McWilliams D, Boime I (1981) J Biol Chem 256: 5121-7 Expression and structures of human placental hormone genes as a function of placental development. Boime I, Boothby M, Hoshina M, Daniels-McQueen S, Darnell R (1982) Biol Reprod 26: 73-91 Diversification of cyclooxygenase-2-derived prostaglandins in ovulation and implantation. Matsumoto H, Ma W, Smalley W, Trzaskos J, Breyer RM, Dey SK (2001) Biol Reprod 64: 1557-65 Increases in testosterone levels and in copulatory behavior of male rhesus monkeys following treatment with human chorionic gonadotrophin. Herndon JG, Allen WC, Blakely RD (1980) Horm Behav 14: 337-47 The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer. Penson DF, Ramsey S, Veenstra D, Clarke L, Gandhi S, Hirsch M (2005) J Urol 174: 547-52; discussion 552 Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study. Graff JN, Mori M, Li H, Garzotto M, Penson D, Potosky AL, Beer TM (2007) J Urol 177: 1307-12 ARF6: a newly appreciated player in G protein-coupled receptor desensitization. Hunzicker-Dunn M, Gurevich VV, Casanova JE, Mukherjee S (2002) FEBS Lett 521: 3-8 Cyclical expression of GnRH and GnRH receptor mRNA in lymphoid organs. Jacobson JD, Crofford LJ, Sun L, Wilder RL (1998) Neuroendocrinology 67: 117-25 Linkage of human chorionic gonadotrophin and placental lactogen biosynthesis to trophoblast differentiation and tumorigenesis. Hoshina M, Boothby M, Hussa R, Pattillo R, Camel HM, Boime I (1985) Placenta 6: 163-72 Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer. Chen RC, Rosenman JG, Hoffman LG, Chiu WK, Wang AZ, Pruthi RS, Wallen EM, Crane JM, Kim WY, Rathmell WK, Godley PA, Whang YE (2012) BJU Int 110: E721-6
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.